• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MAGE-A3(161-175) contains an HLA-DRbeta4 restricted natural epitope poorly formed through indirect presentation by dendritic cells.MAGE - A3(161 - 175)含有一个受HLA - DRβ4限制的天然表位,该表位通过树突状细胞的间接呈递形成不佳。
Cancer Immunol Immunother. 2008 Feb;57(2):207-15. doi: 10.1007/s00262-007-0364-6. Epub 2007 Jul 13.
2
Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.通过用编码具有II类相关恒定链肽基因交换的恒定链的信使核糖核酸进行电穿孔的树突状细胞有效呈递已知的HLA II类限制性MAGE-A3表位。
Cancer Res. 2003 Sep 1;63(17):5587-94.
3
A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes.由HLA-DP4呈递的MAGE-A3肽在肿瘤细胞上被CD4+细胞溶解性T淋巴细胞识别。
Cancer Res. 2000 Nov 15;60(22):6272-5.
4
Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.黑色素瘤细胞将MAGE-3表位呈递给CD4(+) 细胞毒性T细胞,并与组织相容性白细胞抗原DR11相关联。
J Exp Med. 1999 Mar 1;189(5):871-6. doi: 10.1084/jem.189.5.871.
5
MAGE-A3 and MAGE-A4 specific CD4(+) T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes.头颈部癌症患者中 MAGE-A3 和 MAGE-A4 特异性 CD4(+) T 细胞:自然获得性应答的检测和新表位的鉴定。
Cancer Immunol Immunother. 2011 Jan;60(1):23-35. doi: 10.1007/s00262-010-0916-z. Epub 2010 Sep 21.
6
The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses.利用丝状噬菌体fd递送MAGE-A10或MAGE-A3 HLA-A2限制性肽并诱导强烈的抗肿瘤CTL反应。
J Immunol. 2008 Mar 15;180(6):3719-28. doi: 10.4049/jimmunol.180.6.3719.
7
Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes.鉴定由HLA - DR分子呈递给CD4(+) T淋巴细胞的MAGE - 3表位。
J Exp Med. 1999 Mar 1;189(5):767-78. doi: 10.1084/jem.189.5.767.
8
Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy.在基于树突状细胞的免疫治疗后黑色素瘤患者中检测到的肿瘤特异性Th细胞反应的功能分析。
J Immunol. 2004 Jan 15;172(2):1304-10. doi: 10.4049/jimmunol.172.2.1304.
9
The CD4+ T-cell epitope-binding register is a critical parameter when generating functional HLA-DR tetramers with promiscuous peptides.当用混杂肽生成功能性 HLA-DR 四聚体时,CD4+ T 细胞表位结合位是一个关键参数。
Eur J Immunol. 2010 Jun;40(6):1603-16. doi: 10.1002/eji.200940123.
10
Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules.细胞溶解型T淋巴细胞克隆无法识别由MAGE-A3基因编码并由HLA-A24分子呈递的195-203肽段,从而无法识别肿瘤。
Cancer Immunol Immunother. 2007 Feb;56(2):259-69. doi: 10.1007/s00262-006-0186-y. Epub 2006 Jun 7.

引用本文的文献

1
Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma.癌睾丸基因在肾透明细胞癌中的表达及临床意义
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4112-9. eCollection 2014.
2
Evolutionary history of the cancer immunity antigen MAGE gene family.MAGE 基因家族的癌症免疫抗原的进化史。
PLoS One. 2011;6(6):e20365. doi: 10.1371/journal.pone.0020365. Epub 2011 Jun 10.
3
MAGE-A3 and MAGE-A4 specific CD4(+) T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes.头颈部癌症患者中 MAGE-A3 和 MAGE-A4 特异性 CD4(+) T 细胞:自然获得性应答的检测和新表位的鉴定。
Cancer Immunol Immunother. 2011 Jan;60(1):23-35. doi: 10.1007/s00262-010-0916-z. Epub 2010 Sep 21.

本文引用的文献

1
Identification of novel subdominant epitopes on the carcinoembryonic antigen recognized by CD4+ T cells of lung cancer patients.肺癌患者CD4+ T细胞识别的癌胚抗原上新的亚显性表位的鉴定。
J Immunol. 2006 Apr 15;176(8):5093-9. doi: 10.4049/jimmunol.176.8.5093.
2
Augmenting T helper cell immunity in cancer.增强癌症中的辅助性T细胞免疫。
Curr Drug Targets Immune Endocr Metabol Disord. 2005 Dec;5(4):365-71. doi: 10.2174/156800805774913006.
3
Cell biology of antigen processing in vitro and in vivo.体外和体内抗原加工的细胞生物学
Annu Rev Immunol. 2005;23:975-1028. doi: 10.1146/annurev.immunol.22.012703.104538.
4
Endogenous MHC class II processing of a viral nuclear antigen after autophagy.自噬后病毒核抗原的内源性MHC II类加工过程。
Science. 2005 Jan 28;307(5709):593-6. doi: 10.1126/science.1104904. Epub 2004 Dec 9.
5
Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activity.将肿瘤坏死因子-α与αV整合素配体偶联可提高其抗肿瘤活性。
Cancer Res. 2004 Jan 15;64(2):565-71. doi: 10.1158/0008-5472.can-03-1753.
6
Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy.在基于树突状细胞的免疫治疗后黑色素瘤患者中检测到的肿瘤特异性Th细胞反应的功能分析。
J Immunol. 2004 Jan 15;172(2):1304-10. doi: 10.4049/jimmunol.172.2.1304.
7
Mhc-guided processing: binding of large antigen fragments.MHC引导的加工过程:大抗原片段的结合
Nat Rev Immunol. 2003 Aug;3(8):621-9. doi: 10.1038/nri1149.
8
A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein.一种由HLA-DR1呈递给从接种MAGE-3蛋白疫苗的黑色素瘤患者中分离出的CD4+ T细胞的MAGE-3肽。
J Immunol. 2003 Jul 1;171(1):219-25. doi: 10.4049/jimmunol.171.1.219.
9
Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy.通过自噬进行的主要组织相容性复合体II类限制性细胞溶质抗原呈递。
Eur J Immunol. 2003 May;33(5):1250-9. doi: 10.1002/eji.200323730.
10
Tumor-specific shared antigenic peptides recognized by human T cells.被人类T细胞识别的肿瘤特异性共享抗原肽。
Immunol Rev. 2002 Oct;188:51-64. doi: 10.1034/j.1600-065x.2002.18806.x.

MAGE - A3(161 - 175)含有一个受HLA - DRβ4限制的天然表位,该表位通过树突状细胞的间接呈递形成不佳。

MAGE-A3(161-175) contains an HLA-DRbeta4 restricted natural epitope poorly formed through indirect presentation by dendritic cells.

作者信息

Marturano Jill, Longhi Renato, Casorati Giulia, Protti Maria Pia

机构信息

Tumor Immunology Unit, DIBIT, Scientific Institute H. San Raffaele, Milan, Italy.

出版信息

Cancer Immunol Immunother. 2008 Feb;57(2):207-15. doi: 10.1007/s00262-007-0364-6. Epub 2007 Jul 13.

DOI:10.1007/s00262-007-0364-6
PMID:17628799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11030650/
Abstract

We report here that HLA-DRbeta4*01 restricted MAGE-A3(161-175 )specific CD4(+) T cells from a healthy donor recognize a naturally processed epitope formed through the exogenous but not the endogenous pathway. However, the intensity of recognition of the native epitope by MAGE-A3(161-175 )specific CD4(+) T cells strongly depends on the antigen presenting cells and the amount of protein available for processing. EBV-transformed lymphoblastoid cells (LCLs) and melanoma cells engineered to express MAGE-A3 in the endosomal/lysosomal compartment were strongly recognized while autologous dendritic cells loaded with lysate from MAGE-A3 expressing cells were, although significantly, poorly recognized. To prove that the amount of antigen available for processing was a key factor determining the different response LCLs were sorted by MAGE-A3 expression. The response intensity correlated with the amount of MAGE-A3 expressed by the cells. Collectively, these results suggest that different antigen presenting cells with different amount of antigen available for processing as well as protease activity are important factors in determining the epitope repertoire produced in vivo, and therefore reliable tools should be used when testing recognition of native epitopes by peptide specific CD4(+) T cells.

摘要

我们在此报告,来自一名健康供体的HLA-DRβ4*01限制性MAGE-A3(161 - 175)特异性CD4(+) T细胞识别通过外源性而非内源性途径形成的天然加工表位。然而,MAGE-A3(161 - 175)特异性CD4(+) T细胞对天然表位的识别强度强烈依赖于抗原呈递细胞以及可用于加工的蛋白质数量。在内体/溶酶体区室中经基因工程改造表达MAGE-A3的EB病毒转化的淋巴母细胞(LCLs)和黑色素瘤细胞被强烈识别,而负载有来自表达MAGE-A3细胞的裂解物的自体树突状细胞虽然也能被识别,但识别程度明显较差。为了证明可用于加工的抗原量是决定不同反应的关键因素,通过MAGE-A3表达对LCLs进行分选。反应强度与细胞表达的MAGE-A3量相关。总体而言,这些结果表明,具有不同可用于加工的抗原量以及蛋白酶活性的不同抗原呈递细胞是决定体内产生的表位库的重要因素,因此在测试肽特异性CD4(+) T细胞对天然表位的识别时应使用可靠的工具。